Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1849 1
2011 1
2012 1
2013 1
2014 3
2015 4
2016 1
2017 6
2018 9
2019 10
2020 10
2021 13
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Röhrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, Jäger D, Debus J, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: rathke h. J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6. J Nucl Med. 2019. PMID: 30954939 Free PMC article.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, Sandhu S, Kratochwil C, Esfandiari R, Tauber R, Zeldin A, Rathke H, Armstrong WR, Robertson A, Thin P, D'Alessandria C, Rettig MB, Delpassand ES, Haberkorn U, Elashoff D, Herrmann K, Czernin J, Hofman MS, Fendler WP, Eiber M. Gafita A, et al. Among authors: rathke h. Lancet Oncol. 2021 Aug;22(8):1115-1125. doi: 10.1016/S1470-2045(21)00274-6. Epub 2021 Jul 8. Lancet Oncol. 2021. PMID: 34246328 Free article.
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.
Röhrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, Liew DP, Kratochwil C, Rathke H, Liermann J, Herfarth K, Jäger D, Debus J, Haberkorn U, Lang M, Koerber SA. Röhrich M, et al. Among authors: rathke h. J Nucl Med. 2021 Jun 1;62(6):779-786. doi: 10.2967/jnumed.120.253062. Epub 2020 Oct 23. J Nucl Med. 2021. PMID: 33097632 Free PMC article.
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT.
Rathke H, Bruchertseifer F, Kratochwil C, Keller H, Giesel FL, Apostolidis C, Haberkorn U, Morgenstern A. Rathke H, et al. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):311-312. doi: 10.1007/s00259-020-04875-y. Epub 2020 May 28. Eur J Nucl Med Mol Imaging. 2021. PMID: 32468252 No abstract available.
Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.
Glatting FM, Hoppner J, Liew DP, van Genabith A, Spektor AM, Steinbach L, Hubert A, Kratochwil C, Giesel FL, Dendl K, Rathke H, Kauczor HU, Huber PE, Haberkorn U, Röhrich M. Glatting FM, et al. Among authors: rathke h. J Nucl Med. 2022 Dec;63(12):1844-1851. doi: 10.2967/jnumed.122.264069. Epub 2022 May 26. J Nucl Med. 2022. PMID: 35618480
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617.
Kratochwil C, Schmidt K, Afshar-Oromieh A, Bruchertseifer F, Rathke H, Morgenstern A, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: rathke h. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):31-37. doi: 10.1007/s00259-017-3817-y. Epub 2017 Sep 11. Eur J Nucl Med Mol Imaging. 2018. PMID: 28891033 Free PMC article.
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT.
Koerber SA, Finck R, Dendl K, Uhl M, Lindner T, Kratochwil C, Röhrich M, Rathke H, Ungerechts G, Adeberg S, Herfarth K, Jaeger D, Debus J, Haberkorn U, Giesel FL. Koerber SA, et al. Among authors: rathke h. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3918-3924. doi: 10.1007/s00259-021-05374-4. Epub 2021 May 21. Eur J Nucl Med Mol Imaging. 2021. PMID: 34018010 Free PMC article.
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity.
Kratochwil C, Apostolidis L, Rathke H, Apostolidis C, Bicu F, Bruchertseifer F, Choyke PL, Haberkorn U, Giesel FL, Morgenstern A. Kratochwil C, et al. Among authors: rathke h. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):54-63. doi: 10.1007/s00259-021-05474-1. Epub 2021 Aug 26. Eur J Nucl Med Mol Imaging. 2021. PMID: 34448031 Free PMC article.
49 results